(PharmaNewsWire.Com, April 17, 2018 ) The North America market for anticoccidial drugs is estimated to grow from USD 354.6 Million in 2016 to USD 428.4 Million by 2022 at a CAGR of 3.29%. With the ban on consumption of antibiotics as a source of animal feed and the upsurge in antibiotic resistant microbes has reduced the growth of the antibiotic market, nevertheless the rising incidence of coccidiosis over the time and its control on the overall cost to benefit ratio for the meat industry has increased the growth potential of anticoccidials drug market.
Coccidiosis caused by coccidian protozoa, is a parasitic infection of the intestinal tract of animals. The disease feasts from one animal to another by any contact with infected faeces or consumption of infected tissue. It infects a wide variety of animals, such as cattle, poultry species, pigs and sheep. It can be responsible for devastating mislay in meat production. To overcome this problem, anticoccidial drugs play an important role in the prevention and treatment of coccidiosis.
Growing demand for meat proteins is forcing the farmers, mainly in the developed countries to use various antibiotics for maintaining a quality production. Further, the trend of owning companion animals in these nations is increasing the expenditure on antibiotics, driving the North American anticoccidial market.
The North America anticoccidial drugs market is classified based on various types of animals and by type of drugs. The animal segment is sub-categorised into poultry, swine, fish, cattle and companion animals. The companion animal is further segmented into dogs and cats. The livestock segment has a greater potential compares to others. In addition to this, the market is also analysed on the basis of drug type into antibiotic anticoccidials, Ionophore anticoccidials and chemical derivative anticoccidials.
Furthermore, on the basis of geography, the North America market is analysed under various regions namely, USA and Canada. North America leads the global anticoccidial drugs market owing to increased preventive usage of anticoccidials in animal feed. It contributes to around 24% of the worldwide market for anticoccidial drugs with U.S.A holding the largest market share for anticoccidial drugs followed by Canada.
Currently, the major players in the industry are facing complications with the rising incidences of microbial resistance build-up to anticoccidial drugs and government regulations in developed regions, which is compelling them to invest in emerging markets. Some of the key players operating in the market are Bayer Health care, Zoetis, Elanco, Merial, Merck Animal Healthcare, Virbac, Ceva Santé Animale, Boehringer Ingelheim Animal Health, Novartis Animal Healthcare and Smartvet Inc.
About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more info kindly visit, www.marketdataforecast.com
Contact: Abhishek Shukla Sales Manager (International Business Development) Market Data Forecast Direct Line: +1-888-702-9626 Mobile: +91 998 555 0206 Mail: abhishek@marketdataforecast.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
